相关实验视频

Updated: Sep 11, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

准确性ECT:对治疗耐药性抑郁症表观遗传生物标志物的系统审查

Nikolaos Statharakos^1,2, Vasilios Savvidis^1,2, Taxiarchis Gravanis^1,2

¹Department of Child Psychiatry, School of Medicine, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.

Psychiatrike = Psychiatriki

|August 11, 2025

概括

电疗法 (ECT) 在治疗耐药性抑郁症方面表现有前途. 像DNA甲基化和microRNA这样的表观遗传标记可能会影响ECT反应,但需要更多的研究.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
精神病学是一个精神病学.

背景情况:

电疗法 (ECT) 是治疗耐药性重度抑郁症 (TR-MDD) 的高效治疗方法.
驱动ECT治疗功效的精确生物机制在很大程度上是未知的.
表观遗传调节越来越被认为是理解分子对ECT等治疗反应的关键因素.

研究的目的:

系统地审查和综合现有关于与人类人口中ECT结果相关的表观遗传生物标志物的研究.
为了确定特定的表观遗传修饰和基因,涉及到对重度抑郁障碍的ECT反应.
评估关于ECT表观遗传机制的当前知识状态,并突出未来研究领域.

主要方法:

在PubMed和Scopus数据库中对2015年1月至2025年3月期间发表的研究进行了系统的文献搜索.
如果这些研究经过同行评审,调查了ECT诱导的表观遗传变化,并涉及被诊断患有严重抑郁症的患者,则将其纳入.
数据提取侧重于表观遗传目标,患者人口统计,ECT参数和临床结果,并进行偏差风险和异质性评估.

主要成果:

涉及498名TR-MDD患者的11项研究符合纳入标准.
确定了31种潜在的表观遗传生物标志物,包括与神经可塑性,HPA轴功能,炎症,免疫信号和非编码RNA相关的基因.
基因甲基化和microRNA表达是最常被研究的表观遗传机制;在接受ECT的人类中,没有研究过基因组修饰.

结论:

初步证据表明,表观遗传机制,特别是DNA甲基化和microRNA表达,在TR-MDD患者的ECT反应调节中发挥作用.
这些发现为临床分层和精确精神病学方法的开发提供了潜力.
限制包括小样本大小和方法不一致,强调需要更大,标准化和纵向研究来验证这些结果.

关键词:

电疗法是一种电疗法.生物标志物生物标志物表观遗传学是指表观遗传学.精确精神病学是一门精确的精神病学.治疗耐药性抑郁症治疗耐药性抑郁症

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

A Rat Methyl-Seq Platform to Identify Epigenetic Changes Associated with Stress Exposure

A Rat Methyl-Seq Platform to Identify Epigenetic Changes Associated with Stress Exposure

Published on: October 24, 2018

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.